Who Paid My Doc
Synchromedii
Device Drug Infusion Systems
PDI 00643169984226
General payments
$5,838,089
Research payments
$7,153,830
Through program year 2025, $5,838,089 in general payments and $7,153,830 in research payments were reported against Synchromedii (Drug Infusion Systems).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,123,529 | 8,899 |
| 2025 | Research | $1,578,028 | 72 |
| 2024 | General | $1,255,182 | 9,132 |
| 2024 | Research | $1,825,376 | 70 |
| 2023 | General | $1,834,143 | 9,924 |
| 2023 | Research | $1,693,384 | 79 |
| 2022 | General | $1,619,974 | 6,935 |
| 2022 | Research | $2,057,042 | 117 |
| 2021 | General | $5,261 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 87 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
34,893 general · 338 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.